2021 PTAB Year in Review (RECORDING)

Join us as our panel of experts from industry and private practice discusses key PTAB developments from 2021. Important PTAB decisions will be highlighted, as well as impacts on PTAB practice from external sources such as the Supreme Court, Federal Circuit, and Congress. Find out what you need to know about what happened at PTAB last year and what to watch out for in 2022!

This webinar is sponsored by Finnegan, Henderson, Farabow, Garrett & Dunner 

Tom Irving

Partner

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Tom Irving is a partner with Finnegan. He has more than 40 years of experience in the field of intellectual property law. His practice includes America Invents Act (AIA) post-grant proceedings, due diligence, counseling, patent prosecution, and reissue and reexamination. He counsels clients on a wide range of mainly pharmaceutical matters, including pre-litigation, Orange Book listings of patents covering FDA-approved drugs, infringement issues, enforceability and validity analysis.

Mark Feldstein, Ph.D.

Partner

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Mark Feldstein, Ph.D. is a partner at Finnegan. He is a patent and trade secret litigator in U.S. district courts and also serves as lead counsel for clients in post-grant trial proceedings at the USPTO. He also maintains an active patent prosecution practice on behalf of domestic and foreign clients.  His practice encompasses issues involving pharmaceuticals, biochemistry, polymers, small molecule chemistry, nanotechnology, optics, and medical and analytic devices.  He holds a Ph.D. in chemistry.

Joshua Goldberg

Partner

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.

Jessica Marks

Senior Patent Counsel

Unified Patents

Jess Marks prepares and litigates post-grant proceedings before the PTAB for Unified Patents. Prior to joining Unified, Jess practiced at Finnegan, Henderson, Farabow, Garret & Dunner, LLP for over ten years. At Finnegan, Jess litigated post-grant proceedings, district court cases, and International Trade Commission proceedings. Jess is also experienced in licensing negotiations, patent prosecution, due diligence investigations, and opinions on patent infringement, patent validity, and freedom-to-operate. Jess’ cases included electrical, business method, and biological technologies ranging from video surveillance systems, Blu-ray disc players, image processing, artificial intelligence, medical devices, and pharmaceuticals. Jess earned her J.D. from the University of Maryland (now Francis King Carey) School of Law and her M.B.E. and B.A. in Biology from the University of Pennsylvania.

Nichole Valeyko

Patent Attorney

Merck & Co.

Nichole Valeyko is a patent attorney for Merck. Prior to joining Merck in 2019, Nichole worked in private practice for 15 years handling various intellectual property matters, including patent preparation and prosecution, and PTAB proceedings. Nichole has a J.D. from Seton Hall, an M.S. in biotechnology from Johns Hopkins, and a B.S. in biology from Virginia Tech. 

Key:

Complete
Failed
Available
Locked
2021 PTAB Year in Review (RECORDING)
Open to view video.
Open to view video.
Evaluation Survey
13 Questions
CLE Credit
4 Questions
4 Questions CLE credit will be available for registered attendees only. If you would like CLE credit for this webinar, please complete the following questions. IPO will apply for CLE for all live programs in the majority of the states that require CLE. IPO will not be applying for CLE in the states of Florida, Ohio, South Carolina, West Virginia, or Texas (attorneys in TX may submit up to 5 hours of self-study credit). Once IPO has received approval from the state(s) CLE boards , certificate(s) of attendance will be available for download from your dashboard.
CA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available California has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
IL Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Illinois has approved this course for 1 hour of CLE credit. Only registered attendees that viewed the course are eligible to claim credit. To claim credit, select "Claim Credit" then "View/Print Certificate" for your records.
NJ Certificate of Attendance
Up to 1.20 CLE credits available  |  Certificate available
Up to 1.20 CLE credits available  |  Certificate available New Jersey has approved this webinar for 1.2 hours of CLE credit. Only registered attendees that viewed the program are eligible to claim credit. To claim your credit, select "Claim Credits" and then "View/Print your certificate" for your records.
NY Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available This course was approved in Virginia, a NY approved jurisdiction, for 1 hour of CLE credit. Only registered attendees that viewed the program are eligible to claim credit. To claim your credit, select “claim credits” and then “view/print your certificate” for your records.
VA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Virginia has approved this course for 1 hour of CLE credit. Only registered attendees that viewed the course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.